Accueil   Diary - News   All news ADVANCED BIODESIGN, WINNER OF THE I-NOV INNOVATION COMPETITION (WAVE 7) RUN BY THE BPI WITH ITS ALDESCREEN PROJECT

ADVANCED BIODESIGN, WINNER OF THE I-NOV INNOVATION COMPETITION (WAVE 7) RUN BY THE BPI WITH ITS ALDESCREEN PROJECT

 

  • Advanced BioDesign will receive a total of €425,604 in funding to support the development of its ALDESCREEN project over the next three years.

 

  • The ALDESCREEN project aims to develop an early diagnostic test for lung cancer that will allow a more accurate targeting of patients and cancer therapies.

 

 

Lyon, 15th November 2021 – Advanced BioDesign, a French biotechnology company specialising in the development of a new therapy for cancers resistant to standard treatments, has won a call for projects supported by the Investments for the Future Program (PIA) run by the BPI (French public investment bank). As such, the biotech company will benefit from financial aid totalling €425,604 (45% of the total amount) to pursue its project until January 2025.


Advanced BioDesign presented the ALDESCREEN project at the i-Nov Innovation Competition, a support scheme funded by the Investments for the Future Program (PIA), which aims to select innovative projects from companies with the potential to become world leaders in their field.  in the coming months in its first clinical phase.


 

Read the press release